[go: up one dir, main page]

HUP0301646A3 - Clear aqueous anaesthetic composition - Google Patents

Clear aqueous anaesthetic composition

Info

Publication number
HUP0301646A3
HUP0301646A3 HU0301646A HUP0301646A HUP0301646A3 HU P0301646 A3 HUP0301646 A3 HU P0301646A3 HU 0301646 A HU0301646 A HU 0301646A HU P0301646 A HUP0301646 A HU P0301646A HU P0301646 A3 HUP0301646 A3 HU P0301646A3
Authority
HU
Hungary
Prior art keywords
clear aqueous
anaesthetic composition
aqueous anaesthetic
composition
clear
Prior art date
Application number
HU0301646A
Other languages
English (en)
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of HUP0301646A2 publication Critical patent/HUP0301646A2/hu
Publication of HUP0301646A3 publication Critical patent/HUP0301646A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0301646A 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition HUP0301646A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (hu) 2000-06-21 2000-06-21
PCT/IN2000/000124 WO2001097796A1 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition

Publications (2)

Publication Number Publication Date
HUP0301646A2 HUP0301646A2 (hu) 2003-09-29
HUP0301646A3 true HUP0301646A3 (en) 2005-06-28

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301646A HUP0301646A3 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition

Country Status (26)

Country Link
US (1) US7138387B2 (hu)
EP (1) EP1299095B1 (hu)
JP (1) JP4907833B2 (hu)
KR (1) KR100810066B1 (hu)
CN (1) CN1254237C (hu)
AP (1) AP2002002674A0 (hu)
AT (1) ATE267592T1 (hu)
AU (2) AU2001235972B2 (hu)
BG (1) BG107463A (hu)
BR (1) BR0017268A (hu)
CA (1) CA2414064C (hu)
DE (1) DE60011149T2 (hu)
DK (1) DK1299095T3 (hu)
EA (1) EA005589B1 (hu)
ES (1) ES2222271T3 (hu)
HU (1) HUP0301646A3 (hu)
IL (1) IL153387A0 (hu)
IN (1) IN187686B (hu)
MX (1) MXPA02012611A (hu)
NO (1) NO20025999L (hu)
NZ (1) NZ523643A (hu)
PL (1) PL359624A1 (hu)
PT (1) PT1299095E (hu)
WO (1) WO2001097796A1 (hu)
YU (1) YU2703A (hu)
ZA (1) ZA200300336B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (hu) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
US20050042280A1 (en) * 2001-12-28 2005-02-24 Rogers Tracey L. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
CA2474710A1 (en) * 2002-02-01 2003-08-07 Shimoda Biotech (Pty) Ltd Freeze-dried pharmaceutically acceptable inclusion complexes of propofol and cyclodextrin
KR101145692B1 (ko) * 2002-07-29 2012-05-25 트렌스폼 파마수티컬스 인코퍼레이티드 수성 2,6-디이소프로필페놀 약제학적 조성물
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US20050004002A1 (en) * 2002-12-09 2005-01-06 American Bioscience, Inc. Compositions and methods of delivery of pharmacological agents
KR20060130646A (ko) * 2004-01-14 2006-12-19 가부시키가이샤 오츠까 세이야꾸 고죠 프로포폴 함유 지방 유제
BRPI0515181A (pt) * 2004-09-13 2008-07-22 Bharat Serums & Vaccines Ltd composição de óleo-em-água estéril para administração intravenosa, uso de um monoglicerìdeo e processo de preparação de uma composição para administração intravenosa
CN101287447B (zh) * 2005-08-12 2012-10-24 印度血清及疫苗有限公司 包含丙泊酚的水性麻醉剂组合物
WO2007128866A2 (en) * 2006-05-09 2007-11-15 Novobion Oy Novel chemical compositions
US8563221B2 (en) * 2008-03-11 2013-10-22 3M Innovative Properties Company Phototools having a protective layer
WO2010148288A2 (en) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Pharmaceutical formulations with low aqueous levels of free unbound drug
WO2011011167A2 (en) 2009-07-21 2011-01-27 3M Innovative Properties Company Curable composition, method of coating a phototool, and coated phototool
CN102686642B (zh) 2009-09-16 2016-06-29 3M创新有限公司 氟化涂料和用其制作的底片
CN102549042B (zh) 2009-09-16 2015-01-28 3M创新有限公司 氟化涂料和用其制作的底片
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
DK2484350T3 (en) * 2011-02-04 2016-08-01 Norbert Univ -Prof Dr Med Roewer A pharmaceutical composition containing a complex of a cyclodextrin with a propofolsalt
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
ES2784629T3 (es) * 2011-11-29 2020-09-29 Jurox Pty Ltd Composiciones farmacéuticas inyectables estables que comprenden 2-hidroxipropil-beta-ciclodextrina y alfaxalona
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
HUE056838T2 (hu) 2012-08-21 2022-04-28 Sage Therapeutics Inc Allopregnanolon makacs epileptikus állapot kezelésére
EP3407875A4 (en) * 2016-01-29 2019-09-04 Cuda Anesthetics, LLC AQUEOUS PHARMACEUTICAL FORMULATION WITH PROPOFOL
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
IL153387A0 (en) 2003-07-06
AU2001235972B2 (en) 2005-07-21
DE60011149D1 (de) 2004-07-01
MXPA02012611A (es) 2004-07-30
EA005589B1 (ru) 2005-04-28
ZA200300336B (en) 2004-04-08
CA2414064C (en) 2013-01-08
BG107463A (en) 2003-11-28
BR0017268A (pt) 2003-05-27
PL359624A1 (en) 2004-08-23
NO20025999D0 (no) 2002-12-13
NZ523643A (en) 2004-05-28
DK1299095T3 (da) 2004-10-11
ATE267592T1 (de) 2004-06-15
US20040014718A1 (en) 2004-01-22
KR100810066B1 (ko) 2008-03-05
AU3597201A (en) 2002-01-02
IN187686B (hu) 2002-06-08
AP2002002674A0 (en) 2002-12-31
DE60011149T2 (de) 2005-07-07
WO2001097796A1 (en) 2001-12-27
HUP0301646A2 (hu) 2003-09-29
CN1254237C (zh) 2006-05-03
JP4907833B2 (ja) 2012-04-04
PT1299095E (pt) 2004-10-29
CA2414064A1 (en) 2001-12-27
EP1299095A1 (en) 2003-04-09
YU2703A (sh) 2006-03-03
EP1299095B1 (en) 2004-05-26
KR20030023875A (ko) 2003-03-20
JP2003535893A (ja) 2003-12-02
CN1454085A (zh) 2003-11-05
ES2222271T3 (es) 2005-02-01
EA200300047A1 (ru) 2003-06-26
NO20025999L (no) 2002-12-13
US7138387B2 (en) 2006-11-21

Similar Documents

Publication Publication Date Title
HUP0301646A3 (en) Clear aqueous anaesthetic composition
AP2002002700A0 (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
GB0009592D0 (en) Respiratory combinations
GB0020089D0 (en) Vaccine Composition
HUP0400589A3 (en) Colostrum-based composition
SG99895A1 (en) Proanthocyanidin-containing composition
IL145793A0 (en) Odor-eliminating composition
HK1057474A1 (en) Medicinal composition
GB0023891D0 (en) Composition
PL367830A1 (en) Aqueous composition
EP1270611A4 (en) COMPOSITION
SG89421A1 (en) Acidic hairdye composition
GB0109427D0 (en) Arthropod-controlling composition
GB2368847B (en) Aqueous ink composition
IL150471A0 (en) Composition
AU2001287852A8 (en) Composition
GB0007762D0 (en) Composition
GB0009617D0 (en) Respiratory combinations
GB0025058D0 (en) Composition
GB0119165D0 (en) Composition
GB0014971D0 (en) Composition
GB0008118D0 (en) Composition
GB0023420D0 (en) Composition
GB0023416D0 (en) Composition